Jeb Keiper

Jeb Keiper is a seasoned executive in the biotechnology and pharmaceutical industries, currently serving as the CEO and Chief Business Officer at Nimbus Therapeutics since 2014, where responsibilities include overseeing financing, business development, intellectual property, legal matters, and operations. Keiper holds a board member position at ROME Therapeutics and Cardurion Pharmaceuticals, and previously held various senior roles at GlaxoSmithKline, including Vice President of Business Development for GSK Oncology. Additional experience includes managerial roles at McKinsey & Co., TransForm Pharmaceuticals, and Massachusetts General Hospital, with a strong academic background including an MBA from MIT Sloan School of Management and master's and bachelor's degrees in chemical engineering and chemistry from the Massachusetts Institute of Technology.